(genetic basis ) - family studies show that risk of schizophrenia increases with genetic compatibility
Gottesman showed that it can reach up to 48% if they are identical twins
genetic basis a03 - limitation :
reductionist as there are environmental factors such as childhood trauma
genetic basis a03 - strength
strong evidence shown through family studies such as Gottesman and adoption studies such as Tienari et al
shows - some more vulnerable than others sue to genetic makeup
dopamine hypothesis :
neurotransmitters in pre frontal cortex associated with positive symptoms as neurons fire too easily
high numbers of D2 receptors, more dopamine binds to receptors, more neurons fire, increases positive symptoms
deficit of dopamine in pre frontal cortex causes negative symptoms
research - Leutch et al 2013 - meta analysis of 212 studies compares antipsychotics to placebo . findings - drugs more effective at reducing positive and negative symptoms
dopamine hypothesis - a03 strength
evidence for role of dopamine - antipsychotic drugs reduce dopamine and reduce symptoms
shows - there is a biological basis for disease and behaviour
neural correlates :
prefrontalcortex impaired in schizophrenia patients
cognitive impairments, damaged nerve connections and small or damaged hippocampus influences dopamine release and causes negative symptoms
research - vita et al 2012 - patients with schizophrenia compared with controls had a higher reduction in grey matter
neural correlates a03 - limitation
evidence for the role of glutamate - post mortem and live scanning found high levels of glutamate in the brain of schizophrenics
means - other neurotransmitters may play a more central role